Last updated on July 2019

Evaluation iNduction Consolidation and Maintenance Treatment With Isatuximab Carfilzomib LEnalidomide and Dexamethasone

Brief description of study

A Clinical Phase II, multicenter, Open-label study evaluating iNduction, consolidation and maintenance treatment with Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Primary diagnosed high-risk multiple myeloma paTients

Clinical Study Identifier: NCT03104842

Find a site near you

Start Over

St. Antonius Hospital

Eschweiler, Germany
  Connect »